Autologous umbilical cord blood infusion for type 1 diabetes
- 30 June 2008
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 36 (6) , 710-715
- https://doi.org/10.1016/j.exphem.2008.01.009
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Type 1 diabetes intervention trials 2007: where are we and where are we going?Current Opinion in Endocrinology, Diabetes and Obesity, 2007
- Directed engineering of umbilical cord blood stem cells to produce C‐peptide and insulinCell Proliferation, 2007
- Glycemic and Risk Factor Control in Type 1 DiabetesDiabetes Care, 2007
- Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting ß-cell regenerationBrazilian Journal of Medical and Biological Research, 2006
- Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic miceBiochemical and Biophysical Research Communications, 2004
- Gene- and cell-based therapeutics for type I diabetes mellitusGene Therapy, 2003
- Treatment of severe Evans syndrome with an allogeneic cord blood transplantBone Marrow Transplantation, 1997
- Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouseEuropean Journal of Immunology, 1996
- Phenotypic analysis of functional T‐lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantationBritish Journal of Haematology, 1995
- Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation.The Journal of Experimental Medicine, 1993